top of page

why should we invest in digital?

“Why should we invest in a digital therapeutic when it will never come close to generating the revenue we make from our drug portfolio? Why not reinvest into R&D to find the next blockbuster drug, which we definitely know how to do?”

For all the talk of digital disruption in healthcare and pharma, this pointed question from a client cuts to the heart of how many pharma executives approach digital, which in turn informs investment and resource allocation decisions.

Will Pharma ever generate more revenue from a ‘standalone’ digital therapeutic? I doubt it.

Add to the mix the investment required to:

👩‍⚕️ convince physicians to prescribe a digital therapeutic

💰 convince payers to reimburse a digital therapeutic (e.g., properly designed clinical trials showing not just clinical efficacy, but better longer-term efficacy than existing drugs)

🤼 convince internal investment committees and brand managers that a digital therapeutic will not risk or cannibalize the existing drug portfolio or upcoming launches

… and you’ve got a challenging business case to make, which explains why many Pharma companies are still ‘dabbling’ in digital and experimenting at the fringes.

And while dabbling and experimenting is great and often drives progress, when margins get squeezed, it’s often the cost centres (and not the revenue generators) that are impacted the most.

Unfortunately, the digital pharma graveyard is full of many an innovation lab, digital health departments and talented executives...

But that’s why we absolutely love working at the intersection of digital and Pharma, where the business cases are hard, hairy and require an entrepreneurial and non-obvious approach.

I'm optimistic because so far, we’ve seen a handful of strong business arguments able to convince Executive Committees to invest in digital beyond experimenting (and about a dozen arguments which were too indirect, theoretical and often used sexy terms like "AI" and "disruptive innovation" that trigger a lot of executive eye-rolls).

So there’s hope, but it certainly does sometimes feel like pushing a boulder up a hill.

But that's what you get for being a corporate changemaker 👊

Recent Posts

See All

Beyond the buzz...

Having worked at the intersection of digital and pharma since 2008 (before it was sexy), I've had the opportunity to engage many talented executives trying to bring digital into an often risk-averse a

digital health is losing credibility

“It’s been 3 years of strategizing, ideating and experimenting with very little impact - unfortunately, our digital health folks have lost some credibility with the rest of the business” This unfortun

specificity wins the day!

Imagine going for a hike and accidentally falling into a deep hole you can’t climb out of. You look up but all you see is blue sky and the surrounding wall of ground and dirt. Out of the blue, two peo


bottom of page